Brief: Citius Pharmaceuticals, Inc. Reports Fiscal Third Quarter 2022 Financial Results And Provides Business Update
11/08/2022 22:39
Aug 11 (Reuters) - Citius Pharmaceuticals Inc CTXR.O :
* CITIUS PHARMACEUTICALS, INC. REPORTS FISCAL THIRD QUARTER
2022
FINANCIAL RESULTS AND PROVIDES BUSINESS UPDATE
* QTRLY NET LOSS PER SHARE - BASIC AND DILUTED $0.06
* CASH AND CASH EQUIVALENTS OF $48.0 MILLION AS OF JUNE 30,
2022
* Q3 EARNINGS PER SHARE VIEW $-0.05 -- REFINITIV IBES DATA
Source text for Eikon: ID:nPn1dj74Qa
Further company coverage: CTXR.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Citius Pharmaceuticals
See all newsCitius Pharmaceuticals Q2 revenue rises on LYMPHIR launch
Citius Pharmaceuticals reports first revenue of $3.9 mln
Brief: Citius Oncology Expands International Distribution Of Lymphir™ To European Union Through Exclusive Agreement With Uniphar
Brief: Citius Pharmaceuticals, Inc. Reports Fiscal Year 2025 Financial Results And Provides Business Update
Brief: Citius Oncology Announces $18 Million Concurrent Registered Direct Offering And Private Placement Priced At-The-Market Under Nasdaq Rules